发明名称 FUSED-RING COMPOUNDS AND USE THEREOF AS DRUGS
摘要 Fused-ring compounds represented by general formula [I] or the like, or pharmaceutically acceptable salts thereof; and hepatitis C remedies containing the compounds or salts: [I] (wherein each symbol is as defined in the description). The above compounds and salts exhibit an anti-HCV (hepatitis C virus) activity by virtue of their inhibitory activity against HCV polymerase, thus being useful as therapeutic or preventive agents for hepatitis C.
申请公布号 WO0147883(A1) 申请公布日期 2001.07.05
申请号 WO2000JP09181 申请日期 2000.12.22
申请人 JAPAN TOBACCO INC.;HASHIMOTO, HIROMASA;MIZUTANI, KENJI;YOSHIDA, ATSUHITO 发明人 HASHIMOTO, HIROMASA;MIZUTANI, KENJI;YOSHIDA, ATSUHITO
分类号 A61K31/4184;A61K31/42;A61K31/427;A61K31/437;A61K31/4439;A61K31/4523;A61K31/496;A61K31/519;A61K31/52;A61K31/53;A61K31/55;A61K31/7076;A61P1/16;A61P31/20;C07D235/18;C07D235/30;C07D401/04;C07D401/10;C07D401/12;C07D401/14;C07D403/04;C07D403/12;C07D405/04;C07D405/12;C07D409/04;C07D409/12;C07D409/14;C07D413/04;C07D413/12;C07D417/12;C07D495/04;C07D521/00;(IPC1-7):C07D209/12;A61K31/498;A61K31/428;A61K31/422;A61K31/418;A61K31/417;A61K31/407;C07D487/04;C07D471/04;A61K31/506;A61K31/537;A61K31/541;A61K31/433;A61K31/443;A61K31/454;A61K31/470;A61K31/472 主分类号 A61K31/4184
代理机构 代理人
主权项
地址
您可能感兴趣的专利